Cementos Bio-B (CEMENTOS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cementos Bio-B (CEMENTOS) has a cash flow conversion efficiency ratio of -0.003x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CL$-729.01 Million ≈ $-815.29K USD) by net assets (CL$248.18 Billion ≈ $277.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cementos Bio-B - Cash Flow Conversion Efficiency Trend (2014–2021)
This chart illustrates how Cementos Bio-B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Cementos Bio-B for a breakdown of total debt and financial obligations.
Cementos Bio-B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cementos Bio-B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kearny Financial Corp
NASDAQ:KRNY
|
0.019x |
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
0.050x |
|
Shandong Lipeng Co Ltd
SHE:002374
|
0.021x |
|
Nam Long Investment Corp
VN:NLG
|
0.009x |
|
TSRC Corp
TW:2103
|
0.017x |
|
Medigen Vaccine Biologics
TWO:6547
|
0.029x |
|
Shanghai Ailu Package Co. Ltd.
SHE:301062
|
N/A |
|
Shanghai Weihong Electronic Technology Co Ltd
SHE:300508
|
0.035x |
Annual Cash Flow Conversion Efficiency for Cementos Bio-B (2014–2021)
The table below shows the annual cash flow conversion efficiency of Cementos Bio-B from 2014 to 2021. For the full company profile with market capitalisation and key ratios, see Cementos Bio-B market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | CL$257.22 Billion ≈ $287.67 Million |
CL$25.84 Billion ≈ $28.89 Million |
0.100x | -27.10% |
| 2020-12-31 | CL$243.61 Billion ≈ $272.44 Million |
CL$33.56 Billion ≈ $37.54 Million |
0.138x | +8.41% |
| 2019-12-31 | CL$237.85 Billion ≈ $266.00 Million |
CL$30.23 Billion ≈ $33.80 Million |
0.127x | -23.00% |
| 2018-12-31 | CL$231.83 Billion ≈ $259.27 Million |
CL$38.26 Billion ≈ $42.79 Million |
0.165x | +67.48% |
| 2017-12-31 | CL$220.61 Billion ≈ $246.72 Million |
CL$21.74 Billion ≈ $24.31 Million |
0.099x | -63.22% |
| 2016-12-31 | CL$208.81 Billion ≈ $233.52 Million |
CL$55.95 Billion ≈ $62.57 Million |
0.268x | +9.21% |
| 2015-12-31 | CL$202.32 Billion ≈ $226.26 Million |
CL$49.64 Billion ≈ $55.51 Million |
0.245x | +48.09% |
| 2014-12-31 | CL$250.30 Billion ≈ $279.92 Million |
CL$41.47 Billion ≈ $46.38 Million |
0.166x | -- |
About Cementos Bio-B
Cementos Bio Bio S.A. engages in the production and sale of cement, lime, and concrete products in Chile and internationally. The company operates through Cement and Lime segments. It offers ready-mixed concrete, gypsum, and limestone products. The company is also involved in the manufacture and sale of lime for use in the extraction of silver, gold, lithium, and iodine applications, as well as c… Read more